BiotechTube

Cetirizine + Cetirizine

Phase 1Completed
0 watching 0 views this week💤 Quiet
33
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Allergy

Conditions

Allergy

Trial Timeline

Feb 1, 2011 → Mar 1, 2011

NCT ID
NCT01322282

About Cetirizine + Cetirizine

Cetirizine + Cetirizine is a phase 1 stage product being developed by Johnson & Johnson for Allergy. The current trial status is completed. This product is registered under clinical trial identifier NCT01322282. Target conditions include Allergy.

Hype Score Breakdown

Clinical
10
Activity
5
Company
10
Novelty
3
Community
2

Clinical Trials (1)

NCT IDPhaseStatus
NCT01322282Phase 1Completed

Competing Products

20 competing products in Allergy

See all competitors
ProductCompanyStageHype Score
ASP0892 Intradermal + ASP0892 Intramuscular + Placebo Intradermal + Placebo IntramuscularAstellas PharmaPhase 1
33
ASP0892 + PlaceboAstellas PharmaPhase 1
33
Cetirizine 10mg + Cetirizine 10 mg + Cetirizine 10 mgJohnson & JohnsonPhase 1
33
AcalabrutinibAstraZenecaPhase 2
52
OmalizumabNovartisPhase 1
33
ligelizumab + PlaceboNovartisPhase 3
77
remibrutinib + placeboNovartisPhase 2
52
Placebo + XolairNovartisApproved
85
QGE031 + PlaceboNovartisPhase 2
52
Ligelizumab 120 mg + Ligelizumab 240 mgNovartisPhase 3
77
Omalizumab + Placebo for Omalizumab + Multi-Allergen Oral Immunotherapy + Placebo for Multi-Allergen Oral ImmunotherapyNovartisPhase 3
77
QGE031 + PlaceboNovartisPhase 1
33
OmalizumabNovartisApproved
85
Omalizumab InjectionRocheApproved
85
Fluticasone + FluticasonRochePre-clinical
23
Dupilumab + Placebo matching dupilumab + AR101SanofiPhase 2
51
Fexofenadine HCISanofiApproved
84
DupilumabSanofiPhase 2
51
Glucopyranosyl Lipid A (GLA) + Sublingual Immuno Therapy (SLIT) Peanut Extract (PE) + Placebo for GLA + Placebo for SLIT PESanofiPhase 1
32
DupilumabRegeneron PharmaceuticalsPre-clinical
22

Other Products from Johnson & Johnson

Fentanyl transdermal therapeutic systemApproved
85
Nicotine Gum + Nicotine PatchApproved
85
galantamineApproved
85
IbrutinibApproved
85
Paliperidone ERApproved
85